help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 16, 2004
Endocrinology, doi:10.1210/en.2004-1429
A more recent version of this article appeared on March 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/3/1357    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fekete, C.
Right arrow Articles by Lechan, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fekete, C.
Right arrow Articles by Lechan, R. M.

Submitted on November 1, 2004
Accepted on December 6, 2004

Ascending Brainstem Pathways are Not Involved in Lipopolysaccharide-Induced Suppression of TRH Gene Expression in the Hypothalamic Paraventricular Nucleus

Csaba Fekete, Praful S. Singru, Sumit Sarkar, William M. Rand, and Ronald M. Lechan*

Tupper Research Institute and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Tufts-New England Medical Center, Boston, MA 02111. Department of Endocrine Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest H-1083 Hungary. Department of Community Health, Tufts University School of Medicine, Boston, MA 02111. Department of Neuroscience, Tufts University School of Medicine, Boston, MA 02111

* To whom correspondence should be addressed. E-mail: rlechan{at}tufts-nemc.org.

The nonthyroidal illness syndrome associated with fasting, infection and chronic illness, is characterized by low thyroid hormone levels and low or inappropriately normal thyroid-stimulating hormone (TSH) levels in the circulating blood, and reduced synthesis of TSH-releasing hormone (TRH) in hypophysiotropic neurons residing in the hypothalamic paraventricular nucleus (PVN). To test the hypothesis that ascending brain stem pathways are involved in mediation of bacterial lipopolysaccharide (LPS)-induced suppression of TRH mRNA in the PVN, we unilaterally transected brain stem pathways to the PVN and determined the effects of LPS on TRH gene expression, and as a control, on CRH gene expression in hypophysiotropic neurons using semiquantitative in situ hybridization histochemistry. Efficacy of the transection was determined by immunocytochemical detection of ascending adrenergic pathways in the PVN. In vehicle treated animals, CRH mRNA in the PVN showed significant reduction on the transected side compared with intact side, whereas a significant increase in TRH mRNA was observed on the transected side compared with intact side. Following LPS administration (250 µg/100 g BW), a dramatic increase in CRH mRNA was observed on the intact side and a significantly less increase on the transected side. In contrast, LPS treatment resulted in reduction in TRH mRNA on the transected side compared with the intact side, and a significant reduction in TRH mRNA on the transected side compared with vehicle treated animals. These studies confirm an important role of ascending brain stem projections in LPS-induced activation of CRH gene expression, but indicate that they do not mediate the effect of LPS to inhibit hypophysiotropic TRH gene expression.


Key words: Lipopolysaccharide • paraventricular nucleus • in situ hybridization • thyrotropin-releasing hormone (TRH) • corticotropin-releasing hormone (CRH) • brainstem




This article has been cited by other articles:


Home page
EndocrinologyHome page
P. S. Singru, E. Sanchez, R. Acharya, C. Fekete, and R. M. Lechan
Mitogen-Activated Protein Kinase Contributes to Lipopolysaccharide-Induced Activation of Corticotropin-Releasing Hormone Synthesizing Neurons in the Hypothalamic Paraventricular Nucleus
Endocrinology, May 1, 2008; 149(5): 2283 - 2292.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Fuzesi, G. Wittmann, Z. Liposits, R. M. Lechan, and C. Fekete
Contribution of Noradrenergic and Adrenergic Cell Groups of the Brainstem and Agouti-Related Protein-Synthesizing Neurons of the Arcuate Nucleus to Neuropeptide-Y Innervation of Corticotropin-Releasing Hormone Neurons in Hypothalamic Paraventricular Nucleus of the Rat
Endocrinology, November 1, 2007; 148(11): 5442 - 5450.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. R. Klein
The immune system as a regulator of thyroid hormone activity.
Experimental Biology and Medicine, March 1, 2006; 231(3): 229 - 236.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Wittmann, Z. Liposits, R. M. Lechan, and C. Fekete
Origin of Cocaine- and Amphetamine-Regulated Transcript-Containing Axons Innervating Hypophysiotropic Corticotropin-Releasing Hormone-Synthesizing Neurons in the Rat
Endocrinology, July 1, 2005; 146(7): 2985 - 2991.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society